Top compounds associated with response to RASSF3


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib CCLE pan-cancer AAC -0.021 0.7
mRNA WZ-1-84 GDSC1000 pan-cancer AAC 0.024 0.7
mRNA UNC0638 CTRPv2 pan-cancer AAC 0.018 0.7
mRNA ciclosporin CTRPv2 pan-cancer AAC -0.018 0.7
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.7
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC -0.036 0.7
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.017 0.7
mRNA Zibotentan GDSC1000 pan-cancer AAC 0.014 0.7
mRNA Vandetanib CCLE pan-cancer AAC 0.021 0.7
Download CSV